A First-Line CDK4/6 Inhibitor Combination Therapy: Clinical Trial Evidence Complemented by a Real-World Effectiveness Evaluation

Name: A First-Line CDK4/6 Inhibitor Combination Therapy: Clinical Trial Evidence Complemented by a Real-World Effectiveness Evaluation
Start: 2022-12-07T14:00:00-06:00
End: 2022-12-07T15:00:00-06:00

October 31, 2022